Predictors of risks due to adriamycin-based treatment in breast cancer.
Not Applicable
- Conditions
- Health Condition 1: C50- Malignant neoplasm of breast
- Registration Number
- CTRI/2024/06/069073
- Lead Sponsor
- Kasturba Medical College MAHE Manipal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women above the age of 18 years diagnosed with breast cancer and receiving Adriamycin based therapy.
Exclusion Criteria
Women suffering from any other malignancies or on any other anti-cancer drugs.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method